D3S-003

· D3 Bio (Wuxi) Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for D3S-003, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of D3S-003 as Monotherapy in Participants With Advanced Solid Tumors With a KRAS p.G12D Mutation. [Phase 1]

See pricing